Skip to content

KERXKERYX BIOPHARMACEUTICALS

CUSIP 492515101 · common stock

No tracked investor reported shares of KERYX BIOPHARMACEUTICALS (KERX) for Q4 2018. Seth Klarman sold out of its position this quarter.

Holders · Q4 2018
0
New holders
0
Value held
$0
Quarter-end price (est.)
—

Investors holding KERX · Q4 2018

No tracked investor reported shares this quarter.

Sold out this quarter

InvestorPrior weightPrior sharesPrior valueChange
Seth Klarman0.67%25,791,678$87.7MEXIT

History

QuarterHoldersNewSold outValue heldQuarter-end price (est.)
Q4 2018001$0—
Q3 2018100$87.7M$3.40
Q2 2018100$97M$3.76
Q1 2018100$105.5M$4.09
Q4 2017100$119.9M$4.65
Q3 2017100$183.1M$7.10
Q2 2017100$186.5M$7.23
Q1 2017100$158.9M$6.16
Q4 2016100$151.1M$5.86
Q3 2016100$137M$5.31
Q2 2016100$170.7M$6.62
Q1 2016100$120.4M$4.67
Q4 2015100$130.2M$5.05
Q3 2015100$84.5M$3.28
Q2 2015100$257.4M$9.98
Q1 2015100$284.9M$12.73
Q4 2014100$258.9M$14.15
Q3 2014100$251.6M$13.75
Q2 2014100$162.1M$15.38
Q1 2014110$107.5M$17.04